¿¬¼ö°­ÁÂ
2022³â 2ȸ ´ëÇѳ»ºÐºñÇÐȸ ³²¼ºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2022-08-13
2022³â 2ȸ ´ëÇѳ»ºÐºñÇÐȸ ³²¼ºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2022-08-13
±³À°ÀÏÀÚ : 2022-08-13
±³À°Àå¼Ò : ¼ö¿øÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 207È£  
±³À°ÁÖÁ¦ : 2022³â 2ȸ ´ëÇѳ»ºÐºñÇÐȸ ³²¼ºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö 
ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³²¼ºÈ£¸£¸ó¿¬±¸È¸  
´ã´çÀÚ : ³²¼ºÈ£¸£¸ó¿¬±¸È¸ »ç¹«±¹
¿¬¶ôó : 031-705-0549  
À̸ÞÀÏ : pnbbio@pnbbio.com      
±³À°Á¾·ù : ³»°ú, ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í *»çÀüµî·Ï: Àü¹®ÀÇ(30,000), Àü°øÀÇ,¿¬±¸¿ø,°£È£»ç(10,000), Çлý(¹«·á)*ÇöÀåµî·Ï: Àü¹®ÀÇ50,000), Àü°øÀÇ,¿¬±¸¿ø, °£È£»ç(20,000), Çлý(¹«·á)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-13 207È£ 09:00~09:30 Establishing reference intervals of androgens in men  ÀÌÁØÈ£(À»Áö´ëÀÇ´ë, ºñ´¢±â°ú) 
±³À°½Ã°£ 08-13 207È£ 09:30~10:00 Applicability of immunoassay and mass spectrometry in steroid analysis  ÃÖ¸¸È£(KIST(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø)) 
È޽Ġ08-13 207È£ 10:00~10:10 Coffee break  () 
±³À°½Ã°£ 08-13 207È£ 10:10~10:40 Diagnosis of male hypogonadism  ¼­¼ºÈ¯(µ¿¾Æ´ëÀÇ´ë, ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 08-13 207È£ 10:40~11:10 Practical testosterone replacement therapy  ¾È¼øÅÂ(°í·Á´ëÀÇ´ë, ºñ´¢±â°ú) 
±³À°½Ã°£ 08-13 207È£ 11:10~11:50 Androgens, cardiometabolic disease and mortality in men  Yeap Bu Beng(Dept. of Endocrinology and Diabetes, Univ. of Western Australia, Australia) 
±³À°½Ã°£ 08-13 207È£ 11:50~12:10 Testosterone intranasal  Ranjith Ramasamy(Dept. of Urology, Univ. of Miami, USA) 
½Ä»ç 08-13 207È£ 12:10~12:40 Lunch  () 
±³À°½Ã°£ 08-13 207È£ 12:40~13:10 Role of estrogen receptor in Leydig cells  °è¸íÂù(ÇѾç´ë. »ý¸í°úÇаú) 
±³À°½Ã°£ 08-13 207È£ 13:10~13:50 Anabolic steroid withdrawal hypogonadism  Yeap Bu Beng(Dept. of Endocrinology and Diabetes, Univ. of Western Australia, Australia) 
È޽Ġ08-13 207È£ 13:50~14:00 Coffee break  () 
±³À°½Ã°£ 08-13 207È£ 14:00~14:30 Metabolic changes of CAH in steroidogenesis  ±èÁ¤Èñ(¼­¿ï´ëÀÇ´ë, ³»ºÐºñ´ë»ç³»°ú) 
±³À°½Ã°£ 08-13 207È£ 14:30~15:00 Clinical and genetic heterogeneity of congenital adrenal hyperplasia  ÃÖÁøÈ£(¿ï»ê´ëÀÇ´ë, ¼Ò¾Æ³»ºÐºñ´ë»ç°ú) 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[ºÎ»ê] 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17

±³À°ÀÏÀÚ : 2024-04-17 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã´çÀÚ : °­ÈÆ ¿¬¶ôó

Ãßõ¼ö : 0 , Á¶È¸¼ö : 454 , ´ñ±Û¼ö : 0

[´ë±¸] 2023³â Á¦74Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-20

±³À°ÀÏÀÚ : 2023-04-20 ±³À°Àå¼Ò : È£ÅÚ ÀÎÅÍºÒ°í ´ë±¸ ÄÁº¥¼ÇȦAB ¿Ü ±³À°ÁÖÁ¦ : 2023³â Á¦74Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã

Ãßõ¼ö : 0 , Á¶È¸¼ö : 811 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Surgeon : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : °­³²¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Sur

Ãßõ¼ö : 0 , Á¶È¸¼ö : 532 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 16th Vascular Ultrasound Seoul Update 2023 Symposium (2ÀÏÂ÷) : 2024-04-21

±³À°ÀÏÀÚ : 2024-04-21 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 16th Vascular Ultrasound Seoul Update 2023

Ãßõ¼ö : 0 , Á¶È¸¼ö : 473 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 608 , ´ñ±Û¼ö : 0